Methylnaltrexone attenuates taste aversion conditioned by low-dose ethanol

Alcohol
J B Bedingfield, F A Holloway

Abstract

Previous research has shown that activation of a subset of peripheral opioid receptors located in the gut produce aversive effects as measured in the place and taste conditioning (CTA) paradigms. Endogenous opioid activity and tetrahydroisoquinolines (TIQs) are stimulated or formed after ethanol (EtOH) administration and both are known to activate opioid receptors. We therefore examined the hypothesis that a portion of the aversive effects of EtOH may be mediated through peripheral opioid receptors, activated by EtOH-induced opioids or TIQs. EtOH CTAs were slightly attenuated when animals were pretreated with the putative peripheral opioid receptor antagonist methylnaltrexone. By itself MNTX did not condition a taste preference or aversion. However, blood EtOH levels (BELs) in animals pretreated with MNTX were lower than those of saline-pretreated subjects, an effect that just reached statistical significance and was not present at specific EtOH doses. The results indicate that a portion of the aversive conditioning effects of EtOH (using a two-bottle CTA paradigm) may be receptor-mediated effects, exerted by an action on peripheral opioid receptors, but the specific mechanism of attenuation is unclear.

References

Oct 1, 1979·Pharmacology, Biochemistry, and Behavior·D MiceliJ Le Magnen
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·N T BrockwellR J Beninger
May 1, 1990·Pharmacology, Biochemistry, and Behavior·P TothL A Grupp
May 1, 1989·Digestive Diseases and Sciences·D FoschiW Montorsi
Oct 1, 1987·Pharmacology, Biochemistry, and Behavior·A BecharaD van der Kooy
Oct 1, 1987·Pharmacology, Biochemistry, and Behavior·A Bechara, D van der Kooy
Jan 1, 1987·The American Journal of Drug and Alcohol Abuse·M C Trachtenberg, K Blum
Jan 1, 1985·Annals of the New York Academy of Sciences·E GamzuE Boff
Mar 1, 1985·Neuropharmacology·D R Brown, L I Goldberg
Jun 1, 1974·Physiology & Behavior·R F Berman, D S Cannon
Nov 1, 1981·British Journal of Pharmacology·A A Badawy, M Evans
Mar 12, 1982·European Journal of Pharmacology·J RussellH Merz
Jun 1, 1980·Behavioral and Neural Biology·S W KieferJ Garcia
Apr 1, 1996·Alcoholism, Clinical and Experimental Research·L M Veatch, L P Gonzalez
Jan 1, 1996·Alcohol·C P O'BrienJ R Volpicelli
Jun 1, 1992·Behavioural Pharmacology·D.V. GauvinF.A. Holloway

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.